Evidence mapPaperPMID 41688554Full record

ArticleScientific reports2026

Disease-specific crosstalk of Alistipes with lipoprotein profiles in overweight individuals at high cardiometabolic risk.

Amanda Cuevas-Sierra, Andrea Higuera-Gómez, Begoña de Cuevillas, Núria Amigó, María Martínez-Urbistondo, Raquel Castejón, J Antonio Vargas, J Alfredo Martínez

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amanda Cuevas-SierraPrecision Nutrition and Cardiometabolic Health, IMDEA-Nutrition Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI) UAM+CSIC, 28049, Madrid, Spain.
Andrea Higuera-GómezPrecision Nutrition and Cardiometabolic Health, IMDEA-Nutrition Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI) UAM+CSIC, 28049, Madrid, Spain.
Begoña de CuevillasPrecision Nutrition and Cardiometabolic Health, IMDEA-Nutrition Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI) UAM+CSIC, 28049, Madrid, Spain. begona.decuevillas@nutricion.imdea.org.
Núria AmigóBiosfer Teslab, IISPV, CIBERDEM, University Rovira i Virgili. Plaça de Prim, 10, 2° 5ª, 43201, Reus, Tarragona, Spain.
María Martínez-UrbistondoInternal Medicine Service of Puerta de Hierro, Majadahonda University Hospital, 2822, Madrid, Spain.
Raquel CastejónInternal Medicine Service of Puerta de Hierro, Majadahonda University Hospital, 2822, Madrid, Spain.
J Antonio VargasInternal Medicine Service of Puerta de Hierro, Majadahonda University Hospital, 2822, Madrid, Spain.
J Alfredo MartínezPrecision Nutrition and Cardiometabolic Health, IMDEA-Nutrition Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI) UAM+CSIC, 28049, Madrid, Spain.

Funding

Consejería de Educación, Juventud y Deporte, Comunidad de Madrid Y2020/6600Instituto de Salud Carlos III CP25/00072Sara Borrell grant CD22/00011
6 · The paper itself

Abstract

Metabolic syndrome (MS) and systemic lupus erythematosus (SLE) represent two pathophysiologically distinct chronic conditions associated with elevated cardiovascular risk. Emerging evidence links gut microbiota to host lipid metabolism and lipoprotein function. This investigation aimed to analyze disease-specific relations between gut microbiota and an advanced lipoprotein profiling in an overweight population affected by MS and SLE. A total of 85 individuals with MS and 66 with SLE, all overweight, were included. Anthropometric, body composition, and biochemical parameters were assessed. Lipoprotein profiles were quantified by

Indexed as

Cardiovascular DiseasesGastrointestinal MicrobiomeLipoproteinsLupus Erythematosus, SystemicMetabolic SyndromeOverweightAdultCardiometabolic Risk FactorsFemaleHumansMaleMiddle AgedLipoproteinsAdvanced lipoprotein profilingAlistipes- interactionsCardiovascular riskMetabolic syndromeSmall dense LDLSystemic lupus erythematosus

Identifiers

PMID41688554
PMCPMC12993046

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.